🌀 New tool Cochlea Simulator: explore the cochlea in 3D, from the travelling wave to implant stimulation. →🎧 New tool REM & RECD Workshop: measure what the device actually delivers in the ear. →🔧 New tool Device Technology Workshop: from WDRC to frequency lowering, what happens inside a hearing aid? →🎚 Simulator Audiometry Simulator: pure tones, masking and speech tests on a virtual patient. →🧩 Tool Device Selection Workshop: which device type and coupling suits which loss? →🩺 Guide Hearing & Balance Health Guide: from tinnitus to vertigo, A to Z. →🧠 Expert view In-depth pieces for clinicians, academics and graduate students. →📚 Glossary English–Turkish audiology terms, card by card. →📊 ODAK 82 assessment tools and scales in one place. →🎓 Audiology 101 Lecture notes, quizzes and case practice. →📝 New article AI tool CochleaNet assesses every neuron in the gene-treated cochlea one by one →🏛️ Congress notes BAA 2026 Liverpool: notes from the clinical audiology agenda →
Home / Hearing & Balance Health Guide / Ménière’s Disease
◗ Inner ear (labyrinth)

Ménière’s Disease

Ménière’s disease is a chronic inner-ear disorder that causes attacks of vertigo together with fluctuating hearing loss, tinnitus and a feeling of fullness in the ear. There is no cure, but with appropriate management most people can bring the attacks under control and maintain their quality of life.

⏱🔄 Last reviewed: October 2026◈ Evidence-based review

At a glance

What is it?

A chronic inner-ear disorder associated with endolymphatic hydrops, in which episodic vertigo, fluctuating hearing loss, tinnitus and aural fullness occur together.

Main symptoms

Vertigo attacks lasting 20 minutes to 12 hours, with tinnitus, fullness and reduced hearing building up before or during the attack.

Urgency

Attacks are rarely an emergency, but regular follow-up is needed; sudden falls without warning (Tumarkin crises) should always be reported to your doctor.

Main approach

Treatment starts with lifestyle measures and medication; intratympanic treatment or surgery is considered if attacks persist, and hearing aids or a cochlear implant as hearing declines.

Four symptomsVertigo, hearing loss, tinnitus, fullness
Low frequencyFluctuating sensorineural loss
20 min-12 hAttack duration in definite disease
UnilateralUsually begins in one ear

Medical disclaimer. This content is for informational purposes only and does not replace a physician’s examination, diagnosis or treatment; it should not be used as medical advice. For your complaints or personal situation, always consult an ear, nose and throat physician and an audiologist.

!When to see a doctor / audiologist?

If you have recurrent attacks of severe vertigo lasting from 20 minutes to several hours together with fluctuating hearing loss, tinnitus or a feeling of fullness in the ear, see an ear, nose and throat specialist and an audiologist. If you have sudden falls without warning (Tumarkin crises), tell your doctor; if your hearing drops suddenly, seek assessment without delay.

Definition and epidemiology

Ménière’s disease is an idiopathic inner-ear disorder defined by episodic vertigo, fluctuating sensorineural hearing loss, tinnitus and aural fullness. Its characteristic sign is endolymphatic hydrops, an increase in the volume of endolymph in the inner ear (Nakashima et al., 2016).

Reported prevalence varies widely between populations and with the diagnostic criteria used. The disease usually begins in middle age and is slightly more common in women (Nakashima et al., 2016). Symptoms usually begin unilaterally; during follow-up the other ear becomes involved in some patients.

Affected region: Inner ear (labyrinth and endolymphatic system). An increase in endolymph volume (hydrops) produces both hearing and balance symptoms; the hearing loss typically begins at low frequencies and fluctuates.

Symptoms and signs

A typical attack brings severe spinning vertigo lasting from 20 minutes to several hours, often with nausea and vomiting. Before or during the attack, hearing in the affected ear falls and tinnitus and fullness increase.

In the early stage hearing may recover between attacks. As the disease progresses the loss becomes permanent, may take on a flatter configuration, and imbalance may persist between attacks. Some patients have sudden falls without warning or loss of consciousness (Tumarkin crises), which carry a risk of injury.

Causes and risk factors

Most cases are idiopathic. The cause of hydrops has not been fully established; anatomical variations of the endolymphatic sac and duct, autoimmune processes, vascular factors and genetic predisposition have all been proposed.

Salt, caffeine, alcohol and stress are reported to trigger attacks in some patients, but this has not been shown in controlled studies (Hussain et al., 2018). A similar picture arising from a specific identifiable cause is called ‘Ménière’s syndrome’ and is assessed separately.

Audiological and clinical assessment

The diagnosis is clinical. ‘Definite Ménière’s disease’ requires at least two spontaneous vertigo attacks lasting 20 minutes to 12 hours, audiometrically documented low- to mid-frequency sensorineural hearing loss, and fluctuating aural symptoms in the affected ear. The audiometric criterion is bone-conduction thresholds at least 30 dB worse than the other ear at two contiguous frequencies below 2000 Hz. Patients whose attacks last up to 24 hours but who do not meet the audiometric criterion are classed as ‘probable Ménière’s disease’ (Lopez-Escamez et al., 2015).

  • Pure-tone audiometry: required for the diagnosis (Basura et al., 2020). Early disease shows a sensorineural loss that is most marked at low frequencies and changes with attacks; serial audiograms document the fluctuation.
  • Tympanometry and acoustic reflexes: the middle ear is normal; reflexes may be obtained at relatively low sensation levels because of loudness recruitment.
  • Vestibular tests and electrocochleography (ECochG): these can support lateralisation and show vestibular involvement, but the guideline advises against ordering them routinely to establish the diagnosis (Basura et al., 2020).
  • MRI: in asymmetric loss it excludes retrocochlear causes such as vestibular schwannoma; delayed contrast-enhanced inner-ear MRI can show hydrops (Nakashima et al., 2016).
Frequency (Hz) 0 20 40 60 80 100 120 125 250 500 1k 2k 4k 6k 8k Normal limit (25 dB) < < < < Hearing level (dB HL)
Right ear (illustrative)○ Air conduction< Bone conduction Normal limit (25 dB)
Typical audiogram in early Ménière’s disease: a sensorineural loss that is most marked at low frequencies and improves towards the high frequencies (rising configuration); thresholds fluctuate with attacks. The chart is illustrative.

The most important differential diagnosis is vestibular migraine, and the two conditions can coexist in the same person.

Distinguishing Ménière’s disease from vestibular migraine
FeatureMénière’s diseaseVestibular migraine
Attack duration20 min-12 h5 min-72 h
Hearing lossLow-frequency, fluctuating; later permanentUsually absent or mild
Tinnitus/fullnessProminent, worse with attacksVariable
Migraine featuresUncommonHeadache, photophobia, phonophobia, aura
Core mechanismEndolymphatic hydropsCentral migraine mechanisms

Treatment and audiological rehabilitation

Treatment aims to reduce attacks and preserve hearing. Restricting salt, caffeine and alcohol is widely recommended, but a Cochrane review found no randomised controlled trials on the subject (Hussain et al., 2018).

Diuretics and betahistine are commonly prescribed, although in a large placebo-controlled trial betahistine did not reduce attack frequency more than placebo (Adrion et al., 2016). If attacks persist, intratympanic steroids or gentamicin and, in selected cases, surgery are considered; gentamicin carries a risk of hearing loss, and the decision rests with the physician (Basura et al., 2020).

Multi-programme hearing aids can be used when the loss fluctuates, and a cochlear implant is considered in late disease when hearing has fallen permanently to a severe or profound level. Vestibular rehabilitation helps with imbalance that persists between attacks.

Impact on quality of life and advice

Unpredictable attacks can lead to anxiety, depressive symptoms and social withdrawal, and they affect driving and work. Patient-reported measures are useful for tracking the impact of symptoms and the response to treatment.

During an attack, sit or lie down somewhere safe. Between attacks, keep regular sleep and manage stress. Recording attacks, changes in hearing and possible triggers in a diary helps your doctor and audiologist plan treatment.

❝ Cite this page

If you used this review, you can cite it as follows (APA 7):

Auditory Scene. (2026). Ménière’s Disease. Hearing & Balance Health Guide. https://auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/meniere-hastaligi/

Permanent link: auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/meniere-hastaligi/ · Last reviewed: October 2026 · License: CC BY-NC-ND 4.0

References

  1. Adrion, C., Fischer, C. S., Wagner, J., et al. (2016). Efficacy and safety of betahistine treatment in patients with Meniere’s disease: Primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ, 352, h6816.
  2. Basura, G. J., Adams, M. E., Monfared, A., et al. (2020). Clinical practice guideline: Ménière’s disease. Otolaryngology-Head and Neck Surgery, 162(2_suppl), S1-S55.
  3. Hussain, K., Murdin, L., & Schilder, A. G. M. (2018). Restriction of salt, caffeine and alcohol intake for the treatment of Ménière’s disease or syndrome. Cochrane Database of Systematic Reviews, 2018(12), CD012173.
  4. Lopez-Escamez, J. A., Carey, J., Chung, W. H., et al. (2015). Diagnostic criteria for Menière’s disease. Journal of Vestibular Research, 25(1), 1-7.
  5. Nakashima, T., Pyykkö, I., Arroll, M. A., et al. (2016). Ménière’s disease. Nature Reviews Disease Primers, 2, 16028.

Frequently asked questions

Can Ménière’s disease be cured?

There is as yet no treatment that eliminates Ménière’s disease. Even so, with appropriate treatment attacks become less frequent and milder in most patients, and many people continue their usual daily lives. The course varies from person to person, and there may be periods when attacks settle on their own.

Will a low-salt diet stop my attacks?

Restricting salt, caffeine and alcohol is widely recommended and some patients report benefit. However, no randomised trial has shown that these measures reduce attacks. It is best to see dietary changes as one part of a treatment plan agreed with your doctor rather than as a solution on their own.

Will I lose my hearing permanently?

As the disease progresses, hearing loss becomes permanent in some patients; how much and how quickly varies from person to person. Regular audiological monitoring allows changes to be picked up in time. Hearing aids are available for permanent loss, and a cochlear implant for severe to profound loss.

Do I need a hearing aid or a cochlear implant?

Multi-programme hearing aids suit the early stages, when hearing fluctuates. When hearing falls permanently to a severe level and hearing aids no longer give enough benefit, a cochlear implant is considered. Your audiologist and doctor will decide the best option for your hearing level.

How long do the attacks last?

By definition, attacks last from 20 minutes to 12 hours and settle on their own; most are over within a few hours. Tiredness and unsteadiness may linger for a while afterwards. Attacks tend to come and go in clusters, which is why regular follow-up matters.

📊 Related ODAK assessment tools

Scales that can be used to monitor Ménière-specific disability and balance complaints:

⇄ Compare conditions

Pick conditions from the menus and see their features side by side. You can compare up to 4 columns.

Try it in the simulator

Audiometry SimulatorMeasure a low-frequency sensorineural loss on a virtual patient.Open the simulator →